Genprex

© 2023 © 2020 Genprex Inc. All Rights Reserved.

Tagged: China

Genprex Granted Chinese Patent for REQORSA® Immunogene Therapy in Combination with PD-1 Antibodies to Treat Cancers

July 5, 2023

Provides Additional Protection in Large Markets for Therapeutic Combination in Acclaim-2 Phase 1/2 Clinical Trial

Read More